Qube Research & Technologies Ltd
Position in CATX — Perspective Therapeutics, Inc.
CIK 1729829
LONDON, X0
Position in CATX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$65,085
-$158,479 QoQ
Shares Held
15,608
-80.8% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Qube Research & Technologies Ltd holds $992,341,910 across 42 Medical Devices names. CATX ranks #39 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
5,569,880 | $349,509,970 | |
| 2 | SYK |
Stryker Corp
|
578,187 | $189,986,466 | |
| 3 | PODD |
Insulet Corp
|
641,676 | $134,649,291 | |
| 4 | EW |
Edwards Lifesciences Corp
|
795,188 | $63,678,655 | |
| 5 | MASI |
Masimo Corp
|
291,481 | $51,845,725 | |
| 6 | ABT |
Abbott Laboratories
|
334,624 | $34,355,846 | |
| 7 | IRTC |
iRhythm Holdings, Inc.
|
226,884 | $26,776,849 | |
| 8 | HAE |
Haemonetics Corp
|
430,152 | $24,243,366 |
All Filings in CATX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $65,085 | 15,608 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $223,564 | 81,296 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $236,529 | 68,959 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $325,743 | 94,693 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $259,887 | 122,013 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $862,745 | 270,453 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $830,959 | 83,346 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||